COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,009 Articles (22,627 medRxiv, 8,382 bioRxiv)

Most recent first Previous |  Page 1260: Articles 12591-12600  | Next

The effectiveness of Vaxzevria and CoronaVac vaccines: A nationwide longitudinal retrospective study of 61 million Brazilians (VigiVac-COVID19).
Cerqueira-Silva, T., Oliveira, V. d. A., Pescarini, J., Bertoldo Junior, J., Machado, T. M., Ortiz, R. F., Penna, G., Ichihara, M. Y., Venancio de Barros, J., Boaventura, V., Barreto, M. L., Werneck, G. L., Barral-Netto, M.
10.1101/2021.08.21.21261501 — Posted: 2021-08-25 Discussion: Onsite
Temporal Increase in Neutralization Potency of SARS-CoV-2 Antibodies and Reduced Viral Variant Escape after Sputnik V Vaccination
Gonzalez Lopez Ledesma, M. M., Sanchez, L., Ojeda, D. S., Oviedo Rouco, S., Rossi, A. H., Varesse, A., Mazzitelli, I., Pascuale, C. A., Miglietta, E. A., Rodriguez, P. E., Pallares, H. M., Costa Navarro, G. S., Caramelo, J. J., Rothlauf, P. W., Liu, Z., Bloyet, L.-M., Cornejo Pontelli, M., Rasetto, N. B., Wenker, S. D., Ramis, L. Y., Bialer, M. G., de Leone, M. J., Hernando, C. E., Bianchamino, L., Rios, A., Treffinger Cienfuegos, M. S., Rodriguez Garcia, D. R., Longueira, Y., Laufer, N., Alvarez, D., Ceballos, A., Ocho, V., Monzani, C., Turk, G., Salvatori, M., Carradori, J., Prost, K., Rima, A., Varela, C., Ercole, R., Toro, R. I., Gutierrez, S., Zubieta, M., Acuna, D., Nabaes Jodar, M. S., Torres, C., Mojsiejczuk, L., Viegas, M., Velazquez, P., Testa, C., Kreplak, N., Yanovsky, M., Whelan, S., Geffner, J., Pifano, M., Gamarnik, A. V.
10.1101/2021.08.22.21262186 — Posted: 2021-08-25 Discussion: Onsite
A Lagrangian Approach Towards Quantitative Analysis Of Flow-mediated Infection Transmission In Indoor Spaces With Application To SARS-COV-2
Wilson, J., Miller, S. L., Mukherjee, D.
10.1101/2021.08.22.21262447 — Posted: 2021-08-25
All-cause excess mortality in the State of Gujarat, India, during the COVID-19 pandemic (March 2020-April 2021)
Acosta, R. J., Patnaik, B., Buckee, C., Balsari, S., Mahmud, A.
10.1101/2021.08.22.21262432 — Posted: 2021-08-25
Defective ORF8 dimerization in delta variant of SARS CoV2 leads to abrogation of ORF8 MHC-I interaction and overcome suppression of adaptive immune response
Chaudhari, A., Singh, D. I., Joshi, D. M., PATEL, D. A., Joshi, P. C.
10.1101/2021.08.24.457457 — Posted: 2021-08-24
Immunization with SARS-CoV-2 nucleocapsid protein triggers a pulmonary immune response in rats
Silva, E. K. V. B., Bomfim, C. G., Barbosa, A. P., Noda, P., Noronha, I. L., Fernandes, B. H. V., Machado, R. R. G., Durigon, E. L., Catanozi, S., Rodrigues, L. G., Pieroni, F., Lima, S., Queiroz, Z. A. J., Charlie-Silva, I., Silveira, L. K. R., Teodoro, W. T., Capelozzi, V. L., Guzzo, C. R., Fanelli, C.
10.1101/2021.08.24.457520 — Posted: 2021-08-24
Gene Expression Risk Scores for COVID-19 Illness Severity
Peterson, D. R., Baran, A. M., Bhattacharya, S., Branche, A. R., Croft, D. P., Corbett, A. M., Walsh, E. E., Falsey, A. R., Mariani, T. J.
10.1101/2021.08.24.457521 — Posted: 2021-08-24
Discovery of Antiviral Cyclic Peptides Targeting the Main Protease of SARS-CoV-2 via mRNA Display
Johansen-Leete, J., Ullrich, S., Fry, S., Frkic, R., Bedding, M., Aggarwal, A., Ashhurst, A., Ekanayake, K., Mahawaththa, M., Sasi, V., Passioura, T., Larance, M., Otting, G., Turville, S. G., Jackson, C. J., Nitsche, C., Payne, R. J.
10.1101/2021.08.23.457419 — Posted: 2021-08-24
Mutation Y453F in the spike protein of SARS-CoV-2 enhances interaction with the mink ACE2 receptor for host adaption
Ren, W., Lan, J., Ju, X., Gong, M., Long, Q., Zhu, Z., Yu, Y., Wu, J., Zhong, J., Zhang, R., Fan, S., Zhong, G., Huang, A., Wang, X., Ding, Q.
10.1101/2021.08.24.457448 — Posted: 2021-08-24
Structure-based design of antisense oligonucleotides that inhibit SARS-CoV-2 replication
Li, Y., Garcia, G., Arumugaswami, V., Guo, F.
10.1101/2021.08.23.457434 — Posted: 2021-08-24

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).